FDA approves dupilumab for severe eczema
Sign Up to like & getrecommendations! Published in 2017 at "Nature Reviews Drug Discovery"
DOI: 10.1038/nrd.2017.90
Abstract: The new contender seems to offer a lower risk of depression, somnolence and akathisia than the established competition. It still carries a black box warning, however, citing the risk of depression and suicidality. Teva, which… read more here.
Keywords: fda approves; drug; dupilumab severe; approves dupilumab ... See more keywords
The Role of Dupilumab in Severe Asthma
Sign Up to like & getrecommendations! Published in 2021 at "Biomedicines"
DOI: 10.3390/biomedicines9091096
Abstract: Dupilumab is a fully humanized monoclonal antibody, capable of inhibiting intracellular signaling of both interleukin (IL)-4 and IL-13. These are two molecules that, together with other proinflammatory cytokines such as IL-5 and eotaxins, play a… read more here.
Keywords: medicine; severe asthma; dupilumab severe; role ... See more keywords